High-risk blood thinners at discharge from the ER
This trial checks if patients leaving the emergency room or short-stay units while on a blood thinner (anticoagulant) have a higher chance of bleeding or clotting problems. It aims to help doctors give better advice to prevent these issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being discharged from the emergency department or an acute care unit.
- You are currently taking a blood thinner (like warfarin, enoxaparin, dabigatran, rivaroxaban, apixaban, or edoxaban), either as a new or ongoing prescription.
- You are part of the CSAPG healthcare area.
- You are not being discharged from an outpatient clinic, home hospital service, intermediate care, or a residential facility.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether alerting your hospital doctor to prescribe a blood thinner called rivaroxaban (Xarelto) at discharge can help prevent dangerous blood clots in your legs or lungs. It is for patients who are at higher risk for clots but have a low bleeding risk.
This study looks at side effects of blood thinners (anticoagulants) in patients who visited the emergency department. It helps doctors understand how to better manage these medications.
This trial tests ways to improve safety for people with high bleeding risk who take blood thinners after getting a heart stent. It aims to find better quality checks to prevent bleeding and clotting problems.
This trial is testing whether a newer type of blood thinner (called a NOAC) can be used safely right after a heart attack or related event, in addition to the standard two antiplatelet medicines. It focuses on patients who have higher risk signs, like elevated D-dimer levels or a higher PARIS risk score, to see if this approach is safe and effective at preventing future heart problems.
This trial compares two blood thinners (bivalirudin and heparin) during a procedure to open blocked heart arteries (PCI) in patients with a recent heart attack or unstable angina who also have a high risk of bleeding. The goal is to see which drug works better and is safer for patients like you.
This trial is testing a new way to give blood thinners to people who have been in a serious accident. The goal is to see if adjusting the dose based on your blood levels helps prevent dangerous blood clots.
Hear when a new Acute Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.